These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12494248)

  • 21. [Correlation between clinical pathologic factors and enzymatic activity of orotate Phosphoribosyl transferase (OPRT), Dihydropyrimidine dehydrogenase (DPD) and Thymidylate synthase (TS) in colorectal cancer].
    Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Kanazawa Y; Shirakawa T; Ohkawa K; Koizumi M; Ohaki Y; Yamashita K; Tajiri T
    Gan To Kagaku Ryoho; 2006 Jun; 33(6):789-93. PubMed ID: 16770098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
    Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
    Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Selection of anticancer drug for poorly-differentiated adenocarcinoma of colorectum from the level of orotate phosphoribosyl transferase and dihydropyrimidine dehydrogenase activities in cancer tissue].
    Takemura M; Morimura K; Yoshida K; Osugi H; Lee S; Kishida S
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1297-301. PubMed ID: 20647713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TS and DPD mRNA levels on formalin-fixed paraffin-embedded specimens as predictors for distant recurrence of rectal cancer treated with preoperative chemoradiotherapy.
    Tanaka K; Saigusa S; Toiyama Y; Koike Y; Okugawa Y; Yokoe T; Inoue Y; Kobayashi M; Miki C; Kusunoki M
    J Surg Oncol; 2012 May; 105(6):529-34. PubMed ID: 22006578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic impact of orotate phosphoribosyl transferase activity in resectable colorectal cancers treated by 5-fluorouracil-based adjuvant chemotherapy.
    Ochiai T; Nishimura K; Noguchi H; Kitajima M; Tsuruoka Y; Takahashi Y; Tsukada A; Watanabe E; Nagaoka I; Futagawa S
    J Surg Oncol; 2006 Jul; 94(1):45-50. PubMed ID: 16788943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Choice of chemotherapeutic drugs for colorectal cancers by DPD and OPRT activities in cancer tissues].
    Takemura M; Osugi H; Lee S; Kaneko M; Tanaka Y; Fujiwara Y; Nishizawa S; Iwasaki H
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1053-6. PubMed ID: 15272584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dihydropyrimidine dehydrogenase activity and thymidylate synthase level are associated with response to 5-fluorouracil in human colorectal cancer.
    Araki Y; Isomoto H; Shirouzu K
    Kurume Med J; 2001; 48(2):93-8. PubMed ID: 11501504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between 5-fluorouracil sensitivity and single nucleotide polymorphisms of the orotate phosphoribosyl transferase gene in colorectal cancer.
    Kitajima M; Takita N; Hata M; Maeda T; Sakamoto K; Kamano T; Ochiai T
    Oncol Rep; 2006 Jan; 15(1):161-5. PubMed ID: 16328050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlations of clinicopathological factors with protein expression levels of thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyltransferase in colorectal cancer.
    Sumi T; Katsumata K; Tsuchida A; Ishizaki T; Shimazu M; Aoki T
    Chemotherapy; 2010; 56(2):120-6. PubMed ID: 20407238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
    Fukui Y; Oka T; Nagayama S; Danenberg PV; Danenberg KD; Fukushima M
    Int J Mol Med; 2008 Dec; 22(6):709-16. PubMed ID: 19020767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.
    Ichikawa W; Uetake H; Shirota Y; Yamada H; Takahashi T; Nihei Z; Sugihara K; Sasaki Y; Hirayama R
    Br J Cancer; 2003 Oct; 89(8):1486-92. PubMed ID: 14562021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of cut-off values for orotate phosphoribosyl transferase (OPRT) in colorectal cancer using maximal chi 2 values].
    Ochiai T; Sugitani M; Nishimura K; Noguchi H; Okada T; Suda S; Kamiyama H
    Nihon Geka Gakkai Zasshi; 2002 Aug; 103(8):571. PubMed ID: 12229160
    [No Abstract]   [Full Text] [Related]  

  • 33. [Expression of mRNA levels of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase of colorectal cancer--relationships among mRNA levels in association with response to 5-FU based treatment].
    Ishida H; Shirakawa K; Ohsawa T; Sobajima J; Hayashi Y; Nakada H; Yokoyama M; Hashimoto D
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1929-34. PubMed ID: 16282729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis.
    Inokuchi M; Uetake H; Shirota Y; Yamada H; Tajima M; Sugihara K
    Cancer Chemother Pharmacol; 2004 May; 53(5):391-6. PubMed ID: 15060742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of 5-fluorouracil-related enzymes in lung cancer: ELISA characterizes enzyme activity and messenger RNA expression.
    Tsuchida M; Yamato Y; Hashimoto T; Shinohara H; Umezu H; Yoshiya K; Koike T; Hayashi J
    Oncol Rep; 2009 Apr; 21(4):1037-43. PubMed ID: 19288006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orotate phosphoribosyl transferase mRNA expression in oral squamous cell carcinoma and its relationship with the dihydropyrimidine dehydrogenase expression and the clinical effect of 5-fluorouracil.
    Yoshitomi I; Kawasaki G; Yanamoto S; Mizuno A
    Oral Oncol; 2006 Oct; 42(9):880-7. PubMed ID: 16757204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of two fluorouracil administration regimens for colorectal cancer.
    Matsusaka S; Yamasaki H; Kitayama Y; Okada T; Maeda S
    Oncol Rep; 2003; 10(1):109-13. PubMed ID: 12469154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of metabolic enzymes of fluoropyrimidines in primary colorectal cancer and its clinical significance].
    Wang H; Dong PD; Zhang LH; Ji JF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):269-72. PubMed ID: 15968317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of orotate phosphoribosyl transferase in hormone-refractory prostate cancer.
    Tanaka T; Kawashima H; Matsumura K; Yamashita-Hosono T; Yoshimura R; Kuratsukuri K; Harimoto K; Nakatani T
    Oncol Rep; 2009 Jan; 21(1):33-7. PubMed ID: 19082440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-fluorouracil-related gene expression levels in primary colorectal cancer and corresponding liver metastasis.
    Kuramochi H; Hayashi K; Uchida K; Miyakura S; Shimizu D; Vallbohmer D; Park S; Danenberg KD; Takasaki K; Danenberg PV
    Int J Cancer; 2006 Aug; 119(3):522-6. PubMed ID: 16572420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.